Brought to you by:
Pulse IVL system US pivotal trial enrolls first patient
Amplitude Vascular Systems (AVS) recently announced that it has enrolled the first patient in its U.S. pivotal trial for pulsatile intravascular lithotripsy (IVL) therapy. A press release notes that the POWER PAD II clinical study will evaluate the safety and…
Laser atherectomy redefined: Breakthrough 355nm technology opens next frontier in treatment
In this supplement, sponsored by AngioDynamics:
Smoking: BEST-CLI trial points to protective effect against MALE in those undergoing open bypass over endovascular intervention
An analysis of the BEST-CLI randomized controlled trial (RCT) found that smokers with chronic limb-threatening ischemia (CLTI) should be preferentially treated with open bypass over endovascular intervention. Researchers from the University of California San Diego (UCSD) looked at BEST-CLI patients…
The CLTI conundrum: My spirited journey through the CLTI saga
Welcome to the CLTI Chronicles, a saga of mystery, medicine and misadventures in limb salvage unfolding weekly in my office, where the drama of threatened limbs rivals any Latin telenovela. My clinic has become a crossroads for the second opinion…
Eastern Vascular Society presidency transfers from Ozsvath to Lal
Brajesh K. Lal, MD, assumed the Eastern Vascular Society (EVS) presidency during the 2024 EVS annual meeting in Charleston, South Carolina (Sept. 19–22). The professor of surgery at the University of Maryland School of Medicine in Baltimore took over from…
VQI analysis of CLTI practice following BEST-CLI finds no pick up in bypass rate
A Vascular Quality Initiative (VQI) analysis of evolving practice in the wake of the BEST-CLI trial demonstrated no increase in the rate of surgical bypass in the year afterwards. More analysis needs to be done comparing the data pre- and…
‘Select CLTI patients may be safely treated in the office-based lab’
Results from a single-center analysis show the outpatient setting met SVS objective performance goals. A retrospective study of endovascular interventions performed for chronic limb-threatening ischemia (CLTI) in an office-based lab (OBL) associated with a large New York City medical center…
Shockwave Medical expands US peripheral IVL portfolio with enhanced catheter
Shockwave Medical, part of Johnson & Johnson MedTech, has announced the full U.S. launch of its Shockwave E8 peripheral intravascular lithotripsy (IVL) catheter, following clearance by the Food and Drug Administration (FDA). A company press release details that the Shockwave…
The top 10 most popular Vascular Specialist stories of August 2024
In August, the most read stories from Vascular Specialist included a research letter addressing ‘alarmingly high’ mortality rates in chronic limb-threatening ischemia (CLTI) patients; a new book published due to the SVS History Work Group’s recent project; new funding for the development…
Stepping up for vascular health: Challenge commences
The 2024 SVS Foundation’s Vascular Health Step Challenge kicked off Sept. 1 with over 400 registrants committed to walking 60 miles throughout September in honor of Peripheral Arterial Disease (PAD) Awareness Month. With over 60,000 miles of blood vessels in…